Nader Aboul-Fettouh, MD
MOHS-Micrographic Surgery · Allen, TXNPI 1508360298
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Pfizer accounts for 64.6% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $9,826, more than ten times the $170 reported in 2022.
Across 90 payments — averaging $116.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$7K
- Sanofi$714
- LEO Pharma Inc.$546
- Amgen$528
- Galderma Laboratories, L.p.$391
- Sun Pharmaceutical Industries Inc.$389
- plus $1K from 14 others
What the payments were for
- Consulting fees$5,10049%
- Travel & lodging$1,27712%
- Food & beverage$4,00238%
- Education$691%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $6,752 |
| Sanofi | 10 | $714 |
| LEO Pharma Inc. | 10 | $546 |
| Amgen | 11 | $528 |
| Galderma Laboratories, L.p. | 7 | $391 |
| Sun Pharmaceutical Industries Inc. | 9 | $389 |
| Lilly USA, LLC | 4 | $239 |
| Johnson & Johnson | 6 | $151 |
| Almirall LLC | 4 | $120 |
| Novartis | 2 | $106 |
| Boehringer Ingelheim | 1 | $103 |
| Incyte Corporation | 4 | $99 |
| UCB, Inc. | 3 | $76 |
| Janssen Scientific Affairs, LLC | 1 | $64 |
| AbbVie | 2 | $43 |
| Convatec Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Kerecis Limited | 1 | $21 |
| Biofrontera Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,448 in reported general payments places this provider in the 85th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 41 | $297 |
| Doxycycline Hyclate | 13 | $186 |
| Triamcinolone Acetonide | 16 | $178 |
| Tramadol Hcl | 22 | $29 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Allen
- Aaron FarbergRockwall$1.5M
- Suneel ChilukuriBellaire$288K
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Kayla McNieceBellaire$13K
- Hubert ChodkiewiczCedar Park$13K
- Meredith OrsethCedar Hill$12K
- Saira MominGrapevine$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.